Search Orphan Drug Designations and Approvals
-
Generic Name: | liposomal busulfan |
---|---|
Date Designated: | 06/24/2013 |
Orphan Designation: | For use as a conditioning regimen for patients with malignancies undergoing autologous or allogeneic hematopoietic stem cell transplantation |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Calliditas Therapeutics AB Kungsbron 1 Stockholm SE-111 22 Sweden The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-